Indiana University School of Medicine scientists have received the university's largest single grant from the National Institutes of Health and will partner with a team of premier researchers around the country to lead a five-year national research study of a relatively rare form of Alzheimer's disease. Researchers hope the study will provide a foundation that may lead to new therapies for a disease that so far has resisted effective treatment.
IU-led study of younger Alzheimer’s patients aims to pave the way toward new treatments
October 4, 2018
The National Institute on Aging of the NIH has awarded IU a grant that is expected to total $44.7 million to fund the Longitudinal Early-onset Alzheimer's Disease Study. LEADS will follow participants diagnosed with early-onset Alzheimer's disease, which strikes people younger than 65 -- often in their 40s and 50s. The grant is in addition to a $7.6 million award last year that allowed planning and other start-up activity to begin for LEADS, bringing total federal support for the initiative to more than $52 million.
The study is led by IU School of Medicine neurologist and neuroscientist Liana Apostolova, MD, who is partnering with Maria C. Carrillo of the Alzheimer's Association; Brad Dickerson, MD, of Massachusetts General Hospital and Harvard Medical School; and Gil Rabinovici, MD, of University of California San Francisco.
For more on LEADS and the grant award, read the full news release.